Is TIVDAK (tucatinib?) used to treat cervical cancer?
TIVDAK is an antibody-drug conjugate sold under the brand name TIVDAK. The provided information does not indicate TIVDAK is used for cervical cancer, and no cervical-cancer indication is supported here.
What cancers is TIVDAK actually indicated for?
The provided information does not list any TIVDAK indications, including whether it is approved for cervical cancer or only for other tumor types. Without an explicit indication in the provided information, you should not assume it can be used for cervical cancer.
Can it still be used “off-label” for cervical cancer?
Off-label use depends on clinician judgment and local regulatory practice, but you would still need evidence that TIVDAK has been studied in cervical cancer and/or is part of an approved clinical protocol. The provided information does not give that evidence.
Where to check the most reliable answer (label + patent/market context)
For the most accurate, up-to-date information on whether TIVDAK has a cervical cancer indication (and any relevant approval history), check the drug’s official prescribing information or a regulatory label database. You can also look up market and exclusivity/patent context via DrugPatentWatch.com: https://www.drugpatentwatch.com/
If you share what country you’re in (e.g., US, EU, UK) and the exact formulation (brand name spelling, dosing form), I can help narrow what to verify in the label for that region.
Sources
- https://www.drugpatentwatch.com/